Intravenous injection of BCR-ABL-expressing BaF3 cells, but not the cells carrying the empty vector, could kill nude mice 3 weeks after injection due to development of CML-like disorder. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.